These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15549515)

  • 1. Measuring responses to therapy in headache patients: new and traditional end-points.
    D'Amico D; Grazzi L; Usai S; Rigamonti A; Solari A; Bussone G;
    Neurol Sci; 2004 Oct; 25 Suppl 3():S108-10. PubMed ID: 15549515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the impact of migraine.
    Dowson AJ
    Curr Med Res Opin; 2001; 17(4):298-309. PubMed ID: 11922404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disability in young patients suffering from primary headaches.
    Grazzi L; D'Amico D; Usai S; Solari A; Bussone G
    Neurol Sci; 2004 Oct; 25 Suppl 3():S111-2. PubMed ID: 15549516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosing and managing migraine headache.
    Mueller LL
    J Am Osteopath Assoc; 2007 Nov; 107(10 Suppl 6):ES10-6. PubMed ID: 17986672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nebivolol and metoprolol for treating migraine: an advance on beta-blocker treatment?
    Schellenberg R; Lichtenthal A; Wöhling H; Graf C; Brixius K
    Headache; 2008 Jan; 48(1):118-25. PubMed ID: 18184294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition and management of migraine in primary care: influence of functional impact measured by the headache impact test (HIT).
    De Diego EV; Lanteri-Minet M
    Cephalalgia; 2005 Mar; 25(3):184-90. PubMed ID: 15689193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MIDAS questionnaire modification for a new MIDAS junior questionnaire: a clinical experience at the Neurological Institute "C. Besta".
    Grazzi L
    Neurol Sci; 2004 Oct; 25 Suppl 3():S261-2. PubMed ID: 15549553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations of headache diary parameters, quality of life and disability scales.
    Hoppe A; Weidenhammer W; Wagenpfeil S; Melchart D; Linde K
    Headache; 2009 Jun; 49(6):868-78. PubMed ID: 19438730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of an intensive multidisciplinary headache treatment program.
    Gunreben-Stempfle B; Griessinger N; Lang E; Muehlhans B; Sittl R; Ulrich K
    Headache; 2009 Jul; 49(7):990-1000. PubMed ID: 19473281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive treatments for headache.
    Biondi DM
    Expert Rev Neurother; 2005 May; 5(3):355-62. PubMed ID: 15938668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acupuncture for chronic headaches--an epidemiological study.
    Melchart D; Weidenhammer W; Streng A; Hoppe A; Pfaffenrath V; Linde K
    Headache; 2006 Apr; 46(4):632-41. PubMed ID: 16643558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Quality of life and migraine].
    Asensio M; Sánchez R; Montiel I
    Rev Neurol; 1996 Aug; 24(132):926-9. PubMed ID: 8755354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Headache diagnosis, management and morbidity in the Singapore primary care setting: findings from a general practice survey.
    Khu JV; Siow HC; Ho KH
    Singapore Med J; 2008 Oct; 49(10):774-9. PubMed ID: 18946609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
    Freitag FG; Finlayson G; Rapoport AM; Elkind AH; Diamond ML; Unger JR; Fisher AC; Armstrong RB; Hulihan JF; Greenberg SJ;
    Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of migraine is a predictor for response to botulinum toxin type A.
    Eross EJ; Gladstone JP; Lewis S; Rogers R; Dodick DW
    Headache; 2005 Apr; 45(4):308-14. PubMed ID: 15836566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Migraine: a better way to recognize and treat it.
    Landy SH; Kwong WJ; Hutchinson S; Roselli A; Burch SP
    J Fam Pract; 2006 Dec; 55(12):1038-47. PubMed ID: 17137539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in quality of life and activity limitations in migraine patients after prophylaxis. A prospective longitudinal multicentre study.
    D'Amico D; Solari A; Usai S; Santoro P; Bernardoni P; Frediani F; De Marco R; Massetto N; Bussone G;
    Cephalalgia; 2006 Jun; 26(6):691-6. PubMed ID: 16686908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients' preference for migraine preventive therapy.
    Peres MF; Silberstein S; Moreira F; Corchs F; Vieira DS; Abraham N; Gebeline-Myers C
    Headache; 2007 Apr; 47(4):540-5. PubMed ID: 17445103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.